Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination Therapy
Top Cited Papers
- 1 March 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 5 (2) , 241-248
- https://doi.org/10.1161/circheartfailure.111.963991
Abstract
Background—The HeartMate II (HMII) destination therapy (DT) trial demonstrated significant improvements in outcomes in continuous-flow left ventricular assist devices compared with patients implant...Keywords
This publication has 21 references indexed in Scilit:
- Clinical Strategies and Outcomes in Advanced Heart Failure Patients Older Than 70 Years of Age Receiving the HeartMate II Left Ventricular Assist Device: A Community Hospital ExperienceJournal of the American College of Cardiology, 2011
- Left Ventricular Assist Device Therapy in Patients With Restrictive and Hypertrophic CardiomyopathyCirculation: Heart Failure, 2011
- Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart TransplantationJournal of the American College of Cardiology, 2011
- Third INTERMACS Annual Report: The evolution of destination therapy in the United StatesThe Journal of Heart and Lung Transplantation, 2011
- Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure PatientsJournal of the American College of Cardiology, 2010
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- Rise of the Machines — Left Ventricular Assist Devices as Permanent Therapy for Advanced Heart FailureNew England Journal of Medicine, 2009
- Extended Mechanical Circulatory Support With a Continuous-Flow Rotary Left Ventricular Assist DevicePublished by Elsevier ,2009
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in AdultsCirculation, 2009
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007